Yes, that's why the company leadership called the response disappointing. Yeah, it's great news the FDA wants them to conduct a brand new clinical study that will cost millions upon millions of dollars. That's GREAT news!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.